In other organ tumors (stomach, breast and lung adenocarcinoma and squamouscarcinoma), the majority of tumors that highly expressed TONSL mRNA did not exhibit TONSL gene amplification (14.7%, 12.5%, 18.3% and 14.0% respectively), and only a small portion of those tumors were accompanied with TONSL gene amplification (2.2%, 5.0%, 1.8% and 1.8%, respectively). This evidence concerns the gene TONSL and lung adenocarcinoma.